NeuroAxis Analytics

The brain analytics platform behind every Reign-Bow plan

qEEG baselines, personalized TMS protocols, and session-by-session progress dashboards — built so families and physicians can see whether the plan is working, not just hope it is.

Benefits verified prior to treatment

BCBS·Aetna·Cigna·UnitedHealthcare FDA-cleared TMS

Insurance Accepted

BCBS·Aetna·Cigna·UHC

Google Rating

4.9 / 5.0

Highly Rated by Families in Illinois

Physician Reviewed

Every Treatment Plan

Overseen by a licensed physician

FDA-Cleared TMS

Non-Invasive Therapy

For depression, anxiety, OCD

NeuroAxis in 30 seconds

From qEEG to outcome — one connected platform.

  • • 19-channel qEEG baseline
  • • Personalized TMS protocol generation
  • • Session-by-session progress tracking
  • • Repeat qEEG outcome comparison
  • • Physician decision-support
  • • Family-readable reports

qEEG-guided

Treatment plans start from a 19-channel quantitative EEG — not from a symptom checklist alone.

Personalized TMS

Stimulation targets and frequencies are derived from the individual brain map, not a one-size protocol.

Progress-tracked

Session-by-session dashboards let the physician adjust the plan before plateaus become problems.

Outcome-verified

A repeat qEEG at the end confirms whether networks actually changed — not just symptoms reported.

Physician decision-support

Clinicians use NeuroAxis trend data alongside parent reports to course-correct early.

Family-readable

Reports translate brain data into plain language so parents can follow the plan.

Why a platform — not just a protocol

Most clinics deliver TMS the same way to every patient. NeuroAxis exists because two brains with the same diagnosis can need very different protocols. We start with a 19-channel qEEG, identify which networks are over- or under-active, and translate that into a personalized stimulation plan. Then we re-measure. If the data says adjust, we adjust.

The four layers of NeuroAxis

Layer 1

Acquire

19-channel qEEG is recorded in a 60-minute, non-invasive session. Eyes open, eyes closed, and task conditions capture how the brain works under load.

Layer 2

Analyze

NeuroAxis quantifies dysregulation across regulation, attention, communication, sleep, and executive-function networks against age-matched norms.

Layer 3

Treat

A personalized TMS protocol — targets, frequencies, intensities — is generated from the individual map and reviewed by the prescribing physician.

Layer 4

Track

Sessions, tolerance, and parent-reported measures feed continuous dashboards. A repeat qEEG at course end confirms neurological change.

How families experience NeuroAxis

You won't see a clinical dashboard at every visit — but the data behind your child's plan is generated, reviewed, and updated continuously. After the baseline qEEG you receive a written report. After significant milestones you receive a progress summary. At the end of the course we share a repeat qEEG side-by-side with the baseline so you can see what actually changed. Take a guided tour of the family view on the Parent Progress Dashboard.

See what NeuroAxis can show about your child's brain

Verify your insurance benefits or request a consultation — most families hear back within one business day.

Frequently asked questions

What is NeuroAxis?

NeuroAxis is the analytics and decision-support layer behind every Reign-Bow treatment plan. It takes a 19-channel qEEG, surfaces the networks that are dysregulated, generates a personalized TMS protocol, and tracks progress session by session.

Is NeuroAxis a medical device?

No. NeuroAxis is a clinical analytics platform that supports physician decisions. All treatment decisions are made by licensed clinicians; FDA-cleared TMS hardware delivers the therapy.

Can I see my child's NeuroAxis data?

Yes. Families receive a written report after the baseline qEEG and progress updates throughout treatment. We walk you through the data in plain language.

How is NeuroAxis different from MERT?

MERT is one branded protocol. NeuroAxis is a broader analytics platform that supports personalized TMS, progress tracking, outcome monitoring, and re-mapping — not a single proprietary protocol.